Антитела к рецептору ТТГ как предикторы тяжести и исходов эндокринной офтальмопатии у пациентов с болезнью Грейвса
https://doi.org/10.14341/probl201157223-26
Аннотация
Список литературы
1. Wiersinga W.M., Kahaly G.J. (eds.) Graves' Orbitopathy: A Multidisciplinary Approach. Basel Karger 2007;41-55.
2. Drexhage H.A. Are there more than antibodies to the thyroid-stimulating hormone receptor that meet the eye in Graves' disease? Endocrinology 2006;147:1:9-12.
3. Bartalena L., Wiersinga W.M., Pinchera A. Graves' ophthalmopathy: state of the art and perspectives. J Endocrinol Invest 2004;27:3:295-301.
4. Agretti P., De Marco G., De Servi M. et al. Evidence for protein and mRNA TSHr expression in fibroblasts from patients with thyroid-associated ophthalmopathy (TAO) after adipocytic differentiation. Eur J Endocrinol 2005;152:5:777–784.
5. Wakelkamp I.M., Bakker O., Baldeschi L. et al. TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients. Clin Endocrinol 2003;58:3:280-287.
6. Bahn R.S., Gorman C.A. Choice of therapy and criteria for assessing treatment outcome in thyroid-associated ophthalmopathy. Endocrinol Metab Clin North Am 1987;16:2:391-407.
7. Mourits M.P., Prummel M.F., Wiersinga W.M., Koornneef L. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol (Oxf) 1997;47:1:9-14.
8. Werner S.C. Modification of the classification of the eye changes of Graves' disease. Am J Ophthalmol 1977;83:5:725-727.
9. Bartalena L., Baldeschi L., Dickinson A. et al. Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol 2008;158:3:273-285.
10. Eckstein A.K., Plicht M., Lax H. et al. Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab 2006;91:9:3464-3470.
Рецензия
Для цитирования:
, , , , Антитела к рецептору ТТГ как предикторы тяжести и исходов эндокринной офтальмопатии у пациентов с болезнью Грейвса. Проблемы Эндокринологии. 2011;57(2):23-26. https://doi.org/10.14341/probl201157223-26
For citation:
Sviridenko N.I., Likhvantseva V.G., Belovalova I.M., Sheremeta M.S., Tabeeva K.I. Anti-TSH receptor antibodies as predictors of the severity and outcome of endocrine ophthalmopathy in the patients presenting with Graves' disease. Problems of Endocrinology. 2011;57(2):23-26. https://doi.org/10.14341/probl201157223-26
Контент доступен под лицензией Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Послать статью по эл. почте 
.jpg){kind=logo}
